Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2022

Aug 17, 2022

31996_dirs_2022-08-17_0a1d14ff-f952-44ce-923a-3b8f0ac12dd3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2022-08-15

Reporting Person: Holliday Keith (Chief Technology Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-15 Common Stock M 695 $16.15 Acquired 25132 Direct
2022-08-15 Common Stock M 1499 $29.80 Acquired 26631 Direct
2022-08-15 Common Stock M 9388 $35.98 Acquired 36019 Direct
2022-08-15 Common Stock S 11582 $106.32 Disposed 24347 Direct
2022-08-15 Common Stock S 5000 $106.22 Disposed 19437 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-08-15 Common Stock Options $16.15 M 695 Disposed 2028-03-14 Common Stock (695) Direct
2022-08-15 Common Stock Options $29.80 M 1499 Disposed 2028-06-13 Common Stock (1499) Direct
2022-08-15 Common Stock Options $35.98 M 9388 Disposed 2029-03-13 Common Stock (9388) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.51 to $110.88, inclusive.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.66 to $110.20, inclusive.